News

POWER THE COURSE OF FIGHTING DISEASES AND SAVING LIVES
Domain expertise, global resource, long-term capital
PORTFOLIO NEWS
Alebund Pharmaceuticals Announces Collaboration and License Agreement with R1 Therapeutics for AP306
2026年3月17日
AP306 is a first-in-class pan-phosphate transporter inhibitor in development for the treatment of...
Ronovo Surgical advances commercialization in China through Targeted Collaboration Agreement with Johnson & Johnson
2025年9月6日
Shanghai, China – September 5, 2025 – Ronovo Surgical, a global innovator in next-generation...
Belief BioMed and Takeda China jointly announced BBM-H901 (Dalnacogene Ponparvovec Injection), China’s first hemophilia B gene therapy, was officially approved
2025年4月11日
Shanghai, China, April 10, 2025 – Belief BioMed ("BBM") and Takeda China today jointly announced...
More Posts

POWER THE COURSE OF FIGHTING DISEASES AND SAVING LIVES